These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2484788)

  • 21. Coronary bypass: not a cure-all.
    Atkinson JB; Virmani R
    Compr Ther; 1986 Jun; 12(6):48-56. PubMed ID: 2941214
    [No Abstract]   [Full Text] [Related]  

  • 22. PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.
    Reifart N; Störger H; Schwarz F; Rabe A
    Indian Heart J; 1998 Oct; 50 Suppl 1():62-6. PubMed ID: 9824909
    [No Abstract]   [Full Text] [Related]  

  • 23. Tools & techniques: Percutaneous intervention of saphenous vein graft lesions.
    Agostoni P; Voskuil M; Onsea K; Vermeersch P; Stella PR
    EuroIntervention; 2011 Nov; 7(7):878-9. PubMed ID: 22082583
    [No Abstract]   [Full Text] [Related]  

  • 24. Reoperation for coronary artery disease.
    Foster ED
    Circulation; 1985 Dec; 72(6 Pt 2):V59-64. PubMed ID: 3905058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute graft failure caused by an intracoronary shunt in minimally invasive direct coronary artery bypass grafting.
    Izutani H; Gill IS
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):723-4. PubMed ID: 12658217
    [No Abstract]   [Full Text] [Related]  

  • 26. [Histological study of saphenous vein graft disease after coronary artery bypass grafting].
    Kobayashi T; Fuse K; Naruse Y; Watanabe Y; Konishi H
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Apr; 41(4):592-7. PubMed ID: 8515157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelets and thrombosis in vein graft occlusion: role and prevention.
    Lam JY; Solymoss BC; Campeau L
    Cardiovasc Clin; 1991; 21(2):67-81. PubMed ID: 2044097
    [No Abstract]   [Full Text] [Related]  

  • 28. The relationship between saphenous coronary bypass graft occlusion and serum gamma-glutamyltransferase activity.
    Demirkan B; Güray Y; Güray Ü; Turak O; Hajro E; Korkmaz S
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):321-6. PubMed ID: 21200101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radial-artery coronary bypass grafts.
    Khot UN; Friedman DT; Ellis SG
    N Engl J Med; 2005 Mar; 352(9):941-2; author reply 941-2. PubMed ID: 15745991
    [No Abstract]   [Full Text] [Related]  

  • 30. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 31. Percutaneous intervention over the origin of a saphenous vein graft anastomosed with the St. Jude Medical Symmetry Aortic Connector System.
    Fuertes J; Lozano I; Turiel JM; Llosa JC; Suarez E; de la Tassa CM
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):103-6. PubMed ID: 14696167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The saphenous vein graft diseases].
    Yavuz T; Kutsal A
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):50-4, AXVII. PubMed ID: 12101795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraluminal shunting of operatively severed aortocoronary saphenous vein grafts.
    Robison RJ; Brown JW; Deschner WP; King RD
    Ann Thorac Surg; 1986 Oct; 42(4):475-6. PubMed ID: 3490234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary management of vein graft disease.
    Hermiller J
    J Invasive Cardiol; 2005 Aug; 17(8):399-400. PubMed ID: 16079442
    [No Abstract]   [Full Text] [Related]  

  • 35. Contemporary use of embolic protection devices in saphenous vein graft interventions: insights from the stent of saphenous vein grafts trial.
    Heuser RR
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):594. PubMed ID: 21351235
    [No Abstract]   [Full Text] [Related]  

  • 36. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).
    Cataldo G; Braga M; Pirotta N; Lavezzari M; Rovelli F; Marubini E
    Circulation; 1993 Nov; 88(5 Pt 2):II93-8. PubMed ID: 8222202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stenting for saphenous vein graft disease: have we solved the problem?
    Chauhan MS; Carrozza JP
    J Invasive Cardiol; 2000 Oct; 12(10):513-5. PubMed ID: 11022210
    [No Abstract]   [Full Text] [Related]  

  • 38. Early occlusion of saphenous vein grafts due to marked intimal proliferation in Kawasaki disease.
    Nishida H; Endo M; Hayashi H; Koyanagi H; Takao A
    Prog Clin Biol Res; 1987; 250():527-8. PubMed ID: 3501127
    [No Abstract]   [Full Text] [Related]  

  • 39. [Saphenous vein to saphenous vein bypass grafting in four redo CABG patients].
    Ishitoya H; Endo M; Nishida H; Nakano K; Yagi Y; Koyanagi T; Abe R; Yamaki F; Hirota J; Nakatani H
    Kyobu Geka; 1995 Feb; 48(2):100-5. PubMed ID: 7897875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rupture of a saphenous vein coronary artery bypass graft due to Aspergillus necrotizing vasculitis.
    Draganov J; Klein HM; Ghodsizad A; Gehrke M; Gams E
    Ann Thorac Surg; 2005 Aug; 80(2):724-6. PubMed ID: 16039244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.